SAGU · Shreya Acquisition Group

Shreya Acquisition Group exemplifies a classic SPAC structure targeting niche growth sectors like health/wellness, hospitality, media/entertainment, shipping, infrastructure, and waterways tourism. With no operations or revenues to date and a working capital deficit of $216K as of Dec 31, 2025, the $100M IPO proceeds (100% to trust) provide 12 months (extendable to 36) to source and execute a business combination meeting the 80% fair market value test. The sponsor's 4.93M founder shares (purchased for $25K, ~30% post-IPO ownership) create immediate dilution—public shareholders face ~31.5% NTBV drop to $6.85/share at BC (no redemptions)—while anti-dilution conversion rights exacerbate this for public holders. This structure incentivizes sponsor/management to pursue deals even if post-BC share price materially declines, as their low basis ensures substantial profits.

Financially, the SPAC shows no revenue trajectory or unit economics, typical for pre-BC vehicles, but highlights going concern risks from ongoing burn (~$114K net loss YTD Dec 2025). Offering mechanics include 10M units at $10 (greenshoe 1.5M), with deferred underwriting ($0.06/unit) and representative shares (40K Class A to underwriter). Use of proceeds is standard: trust for BC, working capital for diligence/legal. Post-BC, warrants (exercise $11.50, redeemable at $0.01 if shares ≥$18/20-of-30 days) and rights (1/4 share auto-conversion) add ~2.5M shares dilution.

Risks are SPAC-typical but company-specific: sponsor's Mauritius/India ties raise CFIUS hurdles for U.S. targets; management's other fiduciary duties may divert deals; no Rule 419 protections heighten redemption pressure. Competitive positioning leverages management's sector expertise (hospitality/healthcare/media) and networks for proprietary sourcing, emphasizing scalable models with tech integration. Governance includes staggered board, controlled company status pre-BC (Class B voting control), and insider lock-ups (180 days post-BC, 30 days for private units). Overall, high investor risk from dilution/conflicts, but potential upside if management executes in targeted high-growth niches.